Intraocular Lens (IOL) Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Intraocular Lens (IOL) Pipeline Market Report Overview

An intraocular lens is made of plastic, silicone, acrylic, or other material that is implanted inside the eye during cataract surgery. The intraocular lens (IOL) pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Territories ·       The United States

·       Europe

·       Japan

·       India

·       Israel

Key Categories ·       Polymethyl Methacrylate (PMMA) IOL

·       Foldable IOL

·       Monofocal Foldable IOL

·       Toric Foldable IOL

·       Multifocal Foldable IOL

Key Regulatory Paths ·       PMA

·       CE

·       Shonin

·       NMPA

·       ICAC

Leading Companies ·       Adaptilens LLC

·       Adoptics AG (Inactive)

·       AkkoLens International BV

·       Alcon Inc

·       Anew Optics, Inc.

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Intraocular Lens (IOL) Pipeline Market Segmentation by Categories

A few of the key categories in the IOL pipeline market are Polymethyl Methacrylate (PMMA) IOL, Foldable IOL, Monofocal Foldable IOL, Toric Foldable IOL, and Multifocal Foldable IOL. As of September 2024, Polymethyl Methacrylate (PMMA) IOL had the highest number of pipeline products.

IOL Pipeline Market Analysis by Categories, 2024 (%)

IOL Pipeline Market Analysis by Categories, 2024 (%)

Buy the Full Report for More Category Insights into the Intraocular Lens (IOL) Pipeline Market

Download a Free Report Sample

Intraocular Lens (IOL) Pipeline Market Segmentation by Territories

A few of the key territories associated with the IOL pipeline market are Europe, the United States, India, Japan, and Israel among others. As of September 2024, the US had the highest number of Intraocular Lens (IOL) pipeline products.

IOL Pipeline Market Analysis by Territories, 2024 (%)

IOL Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Intraocular Lens (IOL) Pipeline Market

Download a Free Report Sample

Intraocular Lens (IOL) Pipeline Market Segmentation by Regulatory Paths

A few of the key regulatory paths in the IOL pipeline market are PMA, CE, Shonin, NMPA, and ICAC.  As of September 2024, PMA was the most followed pathway for pipeline products in the Intraocular Lens (IOL) market.

IOL Pipeline Market Analysis by Regulatory Paths, 2024 (%)

IOL Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Intraocular Lens (IOL) Pipeline Market

Download a Free Report Sample

Intraocular Lens (IOL) Pipeline Market – Competitive Landscape

A few of the key companies associated with the Intraocular Lens (IOL) pipeline market are Adaptilens LLC, Adoptics AG (Inactive), AkkoLens International BV, Alcon Inc, and Anew Optics, Inc. among others.

AkkoLens International BV: AkkoLens International BV (AkkoLens) is a medical technology company that develops and manufactures innovative ophthalmic solutions. The company offers the Lumina lens, an accommodative intraocular lens (AIOL) designed to restore vision and accommodation.

Alcon Inc: Alcon Inc (Alcon) is engaged in the development and manufacturing of devices in the field of ophthalmology. The company’s portfolio encompasses contact lenses and surgical products, including implantables, consumables and surgical equipment. The company’s products are indicated for the treatment of various conditions such as cataracts, glaucoma, retinal diseases and refractive errors.

IOL Pipeline Market Analysis by Companies, 2024
IOL Pipeline Market Analysis by Companies, 2024
Buy the Full Report for More Company Insights into the Intraocular Lens (IOL) Pipeline Market
Download a Free Report Sample

Segments Covered in the Report

Intraocular Lens (IOL) Pipeline Market Territories Outlook (As of September 2024)

  • Europe
  • The United States
  • India
  • Japan
  • Israel

Intraocular Lens (IOL) Pipeline Market Regulatory Paths Outlook (As of September 2024)

  • PMA
  • CE
  • Shonin
  • NMPA
  • ICAC

Intraocular Lens (IOL) Pipeline Market Categories Outlook (As of September 2024)

  • Polymethyl Methacrylate (PMMA) IOL
  • Foldable IOL
  • Monofocal Foldable IOL
  • Toric Foldable IOL
  • Multifocal Foldable IOL

Scope

This report provides:

  • Extensive coverage of the Intraocular Lens (IOL) devices under development.
  • Exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.
  • Reviews of major players involved in the development of Intraocular Lens (IOL) and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Key clinical trial data of ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of Intraocular Lens (IOL) under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Adaptilens LLC
Adoptics AG (Inactive)
AkkoLens International BV
Alcon Inc
Anew Optics, Inc.
Atia Vision Inc
Bausch & Lomb Inc
Care Group
CEYEBER Corp
Clarvista Medical Inc
ClearSight LLC
Cord LLC
Elenza, Inc.
Emmetrope Incorporated
Eyemed Technologies SRL
ForSight Vision6 Inc
Gaush Meditech Ltd
Henan Universe Intraocular Lens Development Co Ltd
Hoya Surgical Optics Inc
Innovia LLC
Johnson & Johnson Surgical Vision Inc
LensGen Inc
Medicontur Medical Engineering Ltd
Meir Medical Center
Morcher Gmbh
Nayam Innovations Pvt Ltd
Nidek Co Ltd
Northwestern University
NuLens Ltd. (Inactive)
Ocumetics Technology Corp
PhysIOL SA
PowerVision Inc
Presbeasy
Rayner Intraocular Lenses Ltd
Sav-Iol SA
Shanghai Haohai Biological Technology Co Ltd
STAAR Surgical Co
Strathspey Crown LLC
Tianjin Century Kangtai Biomedical Engineering Co Ltd
Ulsan National Institute of Science and Technology
University of East Anglia
University of Rochester
University of Tampere
VA St. Louis Health Care System
Visidome Ltd
Visioneering Technologies Inc
VisusNano Labs
Wakamoto Pharmaceutical Co Ltd
Washington University in St Louis
Xend
Xi'an Eyedele Medical Technology Co Ltd
Z Lens LLC

Table of Contents

|1 Table of Contents

|1.1 List of Tables

|1.2 List of Figures

2 Introduction

2.1 Intraocular Lens (IOL) Overview

3 Products under Development

3.1 Intraocular Lens (IOL) – Pipeline Products by Stage of Development

3.2 Intraocular Lens (IOL) – Pipeline Products by Segment

3.3 Intraocular Lens (IOL) – Pipeline Products by Territory

3.4 Intraocular Lens (IOL) – Pipeline Products by Regulatory Path

3.5 Intraocular Lens (IOL) – Pipeline Products by Estimated Approval Date

3.6 Intraocular Lens (IOL) – Ongoing Clinical Trials

4 Intraocular Lens (IOL) – Pipeline Products under Development by Companies

4.1 Intraocular Lens (IOL) Companies – Pipeline Products by Stage of Development

4.2 Intraocular Lens (IOL) – Pipeline Products by Stage of Development

5 Intraocular Lens (IOL) Companies and Product Overview

5.1 Adaptilens LLC Company Overview

5.1.1 Adaptilens LLC Pipeline Products & Ongoing Clinical Trials Overview

5.2 Adoptics AG (Inactive) Company Overview

5.2.1 Adoptics AG (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.3 AkkoLens International BV Company Overview

5.3.1 AkkoLens International BV Pipeline Products & Ongoing Clinical Trials Overview

5.4 Alcon Inc Company Overview

5.4.1 Alcon Inc Pipeline Products & Ongoing Clinical Trials Overview

5.5 Anew Optics, Inc. Company Overview

5.5.1 Anew Optics, Inc. Pipeline Products & Ongoing Clinical Trials Overview

5.6 Atia Vision Inc Company Overview

5.6.1 Atia Vision Inc Pipeline Products & Ongoing Clinical Trials Overview

5.7 Bausch & Lomb Inc Company Overview

5.7.1 Bausch & Lomb Inc Pipeline Products & Ongoing Clinical Trials Overview

5.8 Care Group Company Overview

5.8.1 Care Group Pipeline Products & Ongoing Clinical Trials Overview

5.9 CEYEBER Corp Company Overview

5.9.1 CEYEBER Corp Pipeline Products & Ongoing Clinical Trials Overview

5.10 Clarvista Medical Inc Company Overview

5.10.1 Clarvista Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

5.11 ClearSight LLC Company Overview

5.11.1 ClearSight LLC Pipeline Products & Ongoing Clinical Trials Overview

5.12 Cord LLC Company Overview

5.12.1 Cord LLC Pipeline Products & Ongoing Clinical Trials Overview

5.13 Elenza, Inc. Company Overview

5.13.1 Elenza, Inc. Pipeline Products & Ongoing Clinical Trials Overview

5.14 Emmetrope Incorporated Company Overview

5.14.1 Emmetrope Incorporated Pipeline Products & Ongoing Clinical Trials Overview

5.15 Eyemed Technologies SRL Company Overview

5.15.1 Eyemed Technologies SRL Pipeline Products & Ongoing Clinical Trials Overview

5.16 ForSight Vision6 Inc Company Overview

5.16.1 ForSight Vision6 Inc Pipeline Products & Ongoing Clinical Trials Overview

5.17 Gaush Meditech Ltd Company Overview

5.17.1 Gaush Meditech Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.18 Henan Universe Intraocular Lens Development Co Ltd Company Overview

5.18.1 Henan Universe Intraocular Lens Development Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.19 Hoya Surgical Optics Inc Company Overview

5.19.1 Hoya Surgical Optics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.20 Innovia LLC Company Overview

5.20.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview

5.21 Johnson & Johnson Surgical Vision Inc Company Overview

5.21.1 Johnson & Johnson Surgical Vision Inc Pipeline Products & Ongoing Clinical Trials Overview

5.22 LensGen Inc Company Overview

5.22.1 LensGen Inc Pipeline Products & Ongoing Clinical Trials Overview

5.23 Medicontur Medical Engineering Ltd Company Overview

5.23.1 Medicontur Medical Engineering Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.24 Meir Medical Center Company Overview

5.24.1 Meir Medical Center Pipeline Products & Ongoing Clinical Trials Overview

5.25 Morcher Gmbh Company Overview

5.25.1 Morcher Gmbh Pipeline Products & Ongoing Clinical Trials Overview

5.26 Nayam Innovations Pvt Ltd Company Overview

5.26.1 Nayam Innovations Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.27 Nidek Co Ltd Company Overview

5.27.1 Nidek Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.28 Northwestern University Company Overview

5.28.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview

5.29 NuLens Ltd. (Inactive) Company Overview

5.29.1 NuLens Ltd. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.30 Ocumetics Technology Corp Company Overview

5.30.1 Ocumetics Technology Corp Pipeline Products & Ongoing Clinical Trials Overview

5.31 PhysIOL SA Company Overview

5.31.1 PhysIOL SA Pipeline Products & Ongoing Clinical Trials Overview

5.32 PowerVision Inc Company Overview

5.32.1 PowerVision Inc Pipeline Products & Ongoing Clinical Trials Overview

5.33 Presbeasy Company Overview

5.33.1 Presbeasy Pipeline Products & Ongoing Clinical Trials Overview

5.34 Rayner Intraocular Lenses Ltd Company Overview

5.34.1 Rayner Intraocular Lenses Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.35 Sav-Iol SA Company Overview

5.35.1 Sav-Iol SA Pipeline Products & Ongoing Clinical Trials Overview

5.36 Shanghai Haohai Biological Technology Co Ltd Company Overview

5.36.1 Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.37 STAAR Surgical Co Company Overview

5.37.1 STAAR Surgical Co Pipeline Products & Ongoing Clinical Trials Overview

5.38 Strathspey Crown LLC Company Overview

5.38.1 Strathspey Crown LLC Pipeline Products & Ongoing Clinical Trials Overview

5.39 Tianjin Century Kangtai Biomedical Engineering Co Ltd Company Overview

5.39.1 Tianjin Century Kangtai Biomedical Engineering Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.40 Ulsan National Institute of Science and Technology Company Overview

5.40.1 Ulsan National Institute of Science and Technology Pipeline Products & Ongoing Clinical Trials Overview

5.41 University of East Anglia Company Overview

5.41.1 University of East Anglia Pipeline Products & Ongoing Clinical Trials Overview

5.42 University of Rochester Company Overview

5.42.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview

5.43 University of Tampere Company Overview

5.43.1 University of Tampere Pipeline Products & Ongoing Clinical Trials Overview

5.44 VA St. Louis Health Care System Company Overview

5.44.1 VA St. Louis Health Care System Pipeline Products & Ongoing Clinical Trials Overview

5.45 Visidome Ltd Company Overview

5.45.1 Visidome Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.46 Visioneering Technologies Inc Company Overview

5.46.1 Visioneering Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview

5.47 VisusNano Labs Company Overview

5.47.1 VisusNano Labs Pipeline Products & Ongoing Clinical Trials Overview

5.48 Wakamoto Pharmaceutical Co Ltd Company Overview

5.48.1 Wakamoto Pharmaceutical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.49 Washington University in St Louis Company Overview

5.49.1 Washington University in St Louis Pipeline Products & Ongoing Clinical Trials Overview

5.50 Xend Company Overview

5.50.1 Xend Pipeline Products & Ongoing Clinical Trials Overview

5.51 Xi’an Eyedele Medical Technology Co Ltd Company Overview

5.51.1 Xi’an Eyedele Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.52 Z Lens LLC Company Overview

5.52.1 Z Lens LLC Pipeline Products & Ongoing Clinical Trials Overview

6 Intraocular Lens (IOL)- Recent Developments

6.1 Sep 06, 2024: SIFI to Present New Products and Scientific Data During the 42nd Congress of the European Society of Cataract and Refractive Surgeons

6.2 Sep 03, 2024: BVI to Launch New SERENITY and SERENITY Toric Premium Monofocal IOLs, Delivering an Extended Range of Vision to More Patients, at the 2024 ESCRS

6.3 Aug 22, 2024: Eyebright Medical Technology Reports Financial Results for H1 of 2024

6.4 Aug 20, 2024: Alcon Announces Results for Three and Six Month Periods Ending June 30, 2024

6.5 Aug 06, 2024: Santen Pharma Announces Consolidated Financial Results for the Three Months Ended June 30, 2024

6.6 Jun 27, 2024: Abbott Hosts Conference Call for Second-Quarter Earnings

6.7 May 29, 2024: Bausch + Lomb’s enVista Envy IOL obtains Health Canada approval

6.8 May 03, 2024: Johnson & Johnson to Present Scientific Data Indicating Benefits of NEW Full Visual Range IOL – TECNIS Odyssey at 2024 Annual ARVO Meeting

6.9 Apr 15, 2024: Bausch + Lomb Will Release First-Quarter 2024 Financial Results on May 1

6.10 Apr 04, 2024: RxSight Announces Commercial Launch of its Newest Light Adjustable Lens™, the LAL+™, and Features Multiple Doctor Presentations at the Upcoming ASCRS Annual Meeting

6.11 Apr 04, 2024: STAAR Surgical Announces Preliminary Net Sales for First Quarter 2024

6.12 Apr 02, 2024: STAAR Surgical Celebrates Three Million Lens Milestone at ASCRS Meeting, Unveils New EVO ICL Data and Latest Innovation for 2024

6.13 Apr 02, 2024: New Data at ASCRS Highlight Alcon Innovations that Optimize Patient Outcomes

6.14 Mar 18, 2024: Staar Surgical Celebrates Three Million Implantable Collamer Lenses

6.15 Mar 12, 2024: Alcon Strengthens Leadership in IOL Innovation with the Launch of the Clareon Presbyopia Correcting IOLs in India

6.16 Mar 06, 2024: STAAR Surgical to Participate in Two Upcoming Investor Conferences

6.17 Feb 16, 2024: Johnson & Johnson unveils presbyopia-correcting IOL in EMEA

6.18 Feb 08, 2024: American Vision Partners Now Offering the Light Adjustable Lens, Customized Vision after Cataract Surgery

6.19 Nov 29, 2023: VISTA Eye Specialist Unveils Innovative Solution for Reading Problems

6.20 Nov 23, 2023: Johnson & Johnson Vision Unveils New Lens, Cataract Surgery Device in Korea

6.21 Oct 10, 2023: Jimmy O. Yang Partners with STAAR Surgical to Shine a Light on Their Vision Correction Lens, EVO ICL

7 Appendix

7.1 Methodology

7.2 About GlobalData

7.3 Contact Us

7.4 Disclaimer

Table

Intraocular Lens (IOL) – Pipeline Products by Stage of Development

Intraocular Lens (IOL) – Pipeline Products by Segment

Intraocular Lens (IOL) – Pipeline Products by Territory

Intraocular Lens (IOL) – Pipeline Products by Regulatory Path

Intraocular Lens (IOL) – Pipeline Products by Estimated Approval Date

Intraocular Lens (IOL) – Ongoing Clinical Trials

Intraocular Lens (IOL) Companies – Pipeline Products by Stage of Development

Intraocular Lens (IOL) – Pipeline Products by Stage of Development

Adaptilens LLC Pipeline Products & Ongoing Clinical Trials Overview

Adaptilens – Product Status

Adaptilens – Product Description

Adoptics AG (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

Shape-Changing Accommodating Intraocular Lens – Product Status

Shape-Changing Accommodating Intraocular Lens – Product Description

AkkoLens International BV Pipeline Products & Ongoing Clinical Trials Overview

Lumina A-IOL – Product Status

Lumina A-IOL – Product Description

Alcon Inc Pipeline Products & Ongoing Clinical Trials Overview

AcrySof IQ ReSTOR 3.0D Toric IOL Diopter Range Expansion – Product Status

AcrySof IQ ReSTOR 3.0D Toric IOL Diopter Range Expansion – Product Description

AcrySof IQ ReSTOR Distant Dominant 2.5D – Product Status

AcrySof IQ ReSTOR Distant Dominant 2.5D – Product Description

AcrySof IQ ReSTOR Toric IOL Diopter Range Expansion – Product Status

AcrySof IQ ReSTOR Toric IOL Diopter Range Expansion – Product Description

AcrySof IQ Toric Diopter Range Expansion – Product Status

AcrySof IQ Toric Diopter Range Expansion – Product Description

AcrySof IQ Toric IOL Low Diopter Range Expansion – Product Status

AcrySof IQ Toric IOL Low Diopter Range Expansion – Product Description

Intrepid IOL – Product Status

Intrepid IOL – Product Description

Next-Gen PanOptix – Product Status

Next-Gen PanOptix – Product Description

Anew Optics, Inc. Pipeline Products & Ongoing Clinical Trials Overview

Zephyr Lens – Product Status

Zephyr Lens – Product Description

Atia Vision Inc Pipeline Products & Ongoing Clinical Trials Overview

OmniVu IOL System – Product Status

OmniVu IOL System – Product Description

Atia Vision Inc – Ongoing Clinical Trials Overview

OmniVu IOL System – A Prospective, Open-label, Single-center Study of the Atia AVL200 Modular Intraocular Lens System for Treatment of Cataract and Presbyopia

Bausch & Lomb Inc Pipeline Products & Ongoing Clinical Trials Overview

enVista Aspire – Product Status

enVista Aspire – Product Description

enVista Dynamic – Product Status

enVista Dynamic – Product Description

enVista Envy – Product Status

enVista Envy – Product Description

enVista Extended Depth of Focus IOL – Product Status

enVista Extended Depth of Focus IOL – Product Description

enVista EY Beyond IOL – Product Status

enVista EY Beyond IOL – Product Description

enVista MX60EF Trifocal IOL – Product Status

enVista MX60EF Trifocal IOL – Product Description

LuxLife (Trifocal) – Product Status

LuxLife (Trifocal) – Product Description

Sarfarazi Elliptical Accommodating IOL – Product Status

Sarfarazi Elliptical Accommodating IOL – Product Description

Bausch & Lomb Inc – Ongoing Clinical Trials Overview

enVista Aspire – A Non-interventional, Prospective, Multicenter, Single Arm, Post-Marketing Clinical Study to Evaluate the enVista Aspire (EA) Intraocular Lens in Subjects Undergoing Cataract Extraction.

enVista Aspire – A Prospective, Single-Center, Randomized Clinical Investigation to Evaluate the Performance of enVista Aspire (EA) Intraocular Lens Against a Control and an Active-Comparator in Subjects Undergoing Cataract Extraction and Implantation of an Intraocular Lens

Care Group Pipeline Products & Ongoing Clinical Trials Overview

Hydrophilic Diffractive IOL – Product Status

Hydrophilic Diffractive IOL – Product Description

Hydrophobic IOL (MICL) – Product Status

Hydrophobic IOL (MICL) – Product Description

IPCL Monofocal – Product Status

IPCL Monofocal – Product Description

Prism IOL – Product Status

Prism IOL – Product Description

Scleral Fixation IOL – Product Status

Scleral Fixation IOL – Product Description

X-Centric IOL – Product Status

X-Centric IOL – Product Description

CEYEBER Corp Pipeline Products & Ongoing Clinical Trials Overview

Third Eye – Product Status

Third Eye – Product Description

Clarvista Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

Second Generation HARMONI System – Product Status

Second Generation HARMONI System – Product Description

ClearSight LLC Pipeline Products & Ongoing Clinical Trials Overview

ClearSight IOL – Product Status

ClearSight IOL – Product Description

ClearSight LLC – Ongoing Clinical Trials Overview

ClearSight IOL – Advanced Perioperative Hemodynamic Monitoring And Clinical Outcome

Cord LLC Pipeline Products & Ongoing Clinical Trials Overview

Model SC9 Lens – Product Status

Model SC9 Lens – Product Description

Elenza, Inc. Pipeline Products & Ongoing Clinical Trials Overview

Sapphire Autofocal IOL – Product Status

Sapphire Autofocal IOL – Product Description

Emmetrope Incorporated Pipeline Products & Ongoing Clinical Trials Overview

ActaLens – Product Status

ActaLens – Product Description

ActaLens-Duo – Product Status

ActaLens-Duo – Product Description

ActaLens-SC – Product Status

ActaLens-SC – Product Description

Eyemed Technologies SRL Pipeline Products & Ongoing Clinical Trials Overview

VaLens – Product Status

VaLens – Product Description

ForSight Vision6 Inc Pipeline Products & Ongoing Clinical Trials Overview

Intraocular Lens – Product Status

Intraocular Lens – Product Description

Gaush Meditech Ltd Pipeline Products & Ongoing Clinical Trials Overview

ACUNEX Quantum – Product Status

ACUNEX Quantum – Product Description

ACUNEX Quantum Toric – Product Status

ACUNEX Quantum Toric – Product Description

FEMTIS Quantum – Product Status

FEMTIS Quantum – Product Description

LENTIS Quantum Toric – Product Status

LENTIS Quantum Toric – Product Description

Henan Universe Intraocular Lens Development Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

PMEA60 Multifocal Intraocular Lens – Product Status

PMEA60 Multifocal Intraocular Lens – Product Description

Henan Universe Intraocular Lens Development Co Ltd – Ongoing Clinical Trials Overview

PMEA60 Multifocal Intraocular Lens – Multicenter Clinical Trial to Evaluate the Efficacy and Safety of Multifocal Intraocular Lens (PMEA60)

Hoya Surgical Optics Inc Pipeline Products & Ongoing Clinical Trials Overview

Artificial Crystalline Lens – Product Status

Artificial Crystalline Lens – Product Description

Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview

Accommodating Intraocular Lens – Product Status

Accommodating Intraocular Lens – Product Description

Johnson & Johnson Surgical Vision Inc Pipeline Products & Ongoing Clinical Trials Overview

IOL Model C0002 – Product Status

IOL Model C0002 – Product Description

TECNIS IOL Model C1V000 – Product Status

TECNIS IOL Model C1V000 – Product Description

TECNIS IOL Model C2V000 – Product Status

TECNIS IOL Model C2V000 – Product Description

Johnson & Johnson Surgical Vision Inc – Ongoing Clinical Trials Overview

IOL Model C0002 – Proof-of-concept Study for New Intraocular Lens, Model C0002

LensGen Inc Pipeline Products & Ongoing Clinical Trials Overview

Juvene – Product Status

Juvene – Product Description

LensGen Inc – Ongoing Clinical Trials Overview

Juvene – A Prospective, Randomized, Controlled, Double-Masked, Phased, Multi-center Clinical Study to Evaluate the Safety and Efficacy of the LensGen Juvene Intraocular Lens

Medicontur Medical Engineering Ltd Pipeline Products & Ongoing Clinical Trials Overview

Hydrophobic IOL – Product Status

Hydrophobic IOL – Product Description

Progressive Varifocal IOL – Product Status

Progressive Varifocal IOL – Product Description

Toric IOL – Product Status

Toric IOL – Product Description

Meir Medical Center Pipeline Products & Ongoing Clinical Trials Overview

PiDO – Product Status

PiDO – Product Description

Morcher Gmbh Pipeline Products & Ongoing Clinical Trials Overview

Anterior Chamber IOL TYPE 54A – Product Status

Anterior Chamber IOL TYPE 54A – Product Description

Anterior Chamber IOL TYPE 54B – Product Status

Anterior Chamber IOL TYPE 54B – Product Description

Anterior Chamber IOLs TYPE 54 – Product Status

Anterior Chamber IOLs TYPE 54 – Product Description

Diplopia IOLs TYPE 85F – Product Status

Diplopia IOLs TYPE 85F – Product Description

Makula IOL TYPE 25B – Product Status

Makula IOL TYPE 25B – Product Description

Microophthalmus IOLs TYPE 27D – Product Status

Microophthalmus IOLs TYPE 27D – Product Description

Myopia IOLs TYPE 22S – Product Status

Myopia IOLs TYPE 22S – Product Description

Myopia IOLs TYPE 71A – Product Status

Myopia IOLs TYPE 71A – Product Description

Myopia IOLs TYPE 71B – Product Status

Myopia IOLs TYPE 71B – Product Description

Phakic IOLs TYPE 99A – Product Status

Phakic IOLs TYPE 99A – Product Description

Phakic IOLs TYPE 99B – Product Status

Phakic IOLs TYPE 99B – Product Description

Phakic IOLs TYPE 99C – Product Status

Phakic IOLs TYPE 99C – Product Description

Phakic IOLs TYPE 99D – Product Status

Phakic IOLs TYPE 99D – Product Description

Sclera IOLs Type 27L – Product Status

Sclera IOLs Type 27L – Product Description

Sclera IOLs Type 53S – Product Status

Sclera IOLs Type 53S – Product Description

Sclera IOLs Type 66 – Product Status

Sclera IOLs Type 66 – Product Description

Sclera IOLs Type 81B – Product Status

Sclera IOLs Type 81B – Product Description

Nayam Innovations Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview

E-SITE – Product Status

E-SITE – Product Description

I-SITE – Product Status

I-SITE – Product Description

Nidek Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Nidek Toric Intraocular Lens – Product Status

Nidek Toric Intraocular Lens – Product Description

Northwestern University Pipeline Products & Ongoing Clinical Trials Overview

3D Printed Intraocular Lens – Product Status

3D Printed Intraocular Lens – Product Description

NuLens Ltd. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

NuLens Dynacurvature IOL – Product Status

NuLens Dynacurvature IOL – Product Description

Ocumetics Technology Corp Pipeline Products & Ongoing Clinical Trials Overview

Bionic Lens – Product Status

Bionic Lens – Product Description

PhysIOL SA Pipeline Products & Ongoing Clinical Trials Overview

FineVision HP – Product Status

FineVision HP – Product Description

PowerVision Inc Pipeline Products & Ongoing Clinical Trials Overview

FluidVision Lens – Product Status

FluidVision Lens – Product Description

PowerVision Inc – Ongoing Clinical Trials Overview

FluidVision Lens – Randomized Controlled Study of Fluid Accommodating IOL Outcomes Versus Monofocal Control

Presbeasy Pipeline Products & Ongoing Clinical Trials Overview

Presbeasy Lens – Product Status

Presbeasy Lens – Product Description

Rayner Intraocular Lenses Ltd Pipeline Products & Ongoing Clinical Trials Overview

Next Generation Intraocular Lens – Product Status

Next Generation Intraocular Lens – Product Description

P-flex – Product Status

P-flex – Product Description

Sav-Iol SA Pipeline Products & Ongoing Clinical Trials Overview

R-TASC – Product Status

R-TASC – Product Description

Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Hydrophobic Molded Toric Aspheric IOL – Product Status

Hydrophobic Molded Toric Aspheric IOL – Product Description

Innovative Casting Molded Hydrophobic Aspheric IOL – Product Status

Innovative Casting Molded Hydrophobic Aspheric IOL – Product Description

Innovative Pre-loaded IOL – Product Status

Innovative Pre-loaded IOL – Product Description

Ortho K-Lens – Product Status

Ortho K-Lens – Product Description

STAAR Surgical Co Pipeline Products & Ongoing Clinical Trials Overview

STAAR Accomodating IOL – Product Status

STAAR Accomodating IOL – Product Description

Visian Implantable Collamer Lens – V5 – Product Status

Visian Implantable Collamer Lens – V5 – Product Description

Visian Implantable Collamer Lens V6a – Product Status

Visian Implantable Collamer Lens V6a – Product Description

Visian Implantable Collamer Lens V6b – Product Status

Visian Implantable Collamer Lens V6b – Product Description

Strathspey Crown LLC Pipeline Products & Ongoing Clinical Trials Overview

Camera-Integrated Acrylic IOLs – Product Status

Camera-Integrated Acrylic IOLs – Product Description

Tianjin Century Kangtai Biomedical Engineering Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Diffractive Multifocal Intraocular Lens – Product Status

Diffractive Multifocal Intraocular Lens – Product Description

Ulsan National Institute of Science and Technology Pipeline Products & Ongoing Clinical Trials Overview

Smart Contact Lens Sensor – Product Status

Smart Contact Lens Sensor – Product Description

University of East Anglia Pipeline Products & Ongoing Clinical Trials Overview

Intraocular Lens – Cataract – Product Status

Intraocular Lens – Cataract – Product Description

University of Rochester Pipeline Products & Ongoing Clinical Trials Overview

Multifocal Ophthalmic Lens – Product Status

Multifocal Ophthalmic Lens – Product Description

University of Tampere Pipeline Products & Ongoing Clinical Trials Overview

Artificial Lens – Product Status

Artificial Lens – Product Description

VA St. Louis Health Care System Pipeline Products & Ongoing Clinical Trials Overview

Intraocular Lens – Product Status

Intraocular Lens – Product Description

Visidome Ltd Pipeline Products & Ongoing Clinical Trials Overview

Accomodative IOL – Product Status

Accomodative IOL – Product Description

Visioneering Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview

Intraocular Lens – Product Status

Intraocular Lens – Product Description

VisusNano Labs Pipeline Products & Ongoing Clinical Trials Overview

MEDILens – Product Status

MEDILens – Product Description

Wakamoto Pharmaceutical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

WP-2011 Multifocal Intraocular Lens – Product Status

WP-2011 Multifocal Intraocular Lens – Product Description

Wakamoto Pharmaceutical Co Ltd – Ongoing Clinical Trials Overview

WP-2011 Multifocal Intraocular Lens – WP-2011: An Open-label Study of Multifocal Intraocular Lenses in Aphakic Patients after Cataract Surgery

Washington University in St Louis Pipeline Products & Ongoing Clinical Trials Overview

Intraocular Artificial Lens – Product Status

Intraocular Artificial Lens – Product Description

Xend Pipeline Products & Ongoing Clinical Trials Overview

Intraocular Lens – Product Status

Intraocular Lens – Product Description

Xi’an Eyedele Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Polyolefin Intraocular Lens – Product Status

Polyolefin Intraocular Lens – Product Description

Z Lens LLC Pipeline Products & Ongoing Clinical Trials Overview

AD-IOL System – Product Status

AD-IOL System – Product Description

Glossary

Figures

Intraocular Lens (IOL) – Pipeline Products by Stage of Development

Intraocular Lens (IOL) – Pipeline Products by Segment

Intraocular Lens (IOL) – Pipeline Products by Territory

Intraocular Lens (IOL) – Pipeline Products by Regulatory Path

Intraocular Lens (IOL) – Pipeline Products by Estimated Approval Date

Intraocular Lens (IOL) – Ongoing Clinical Trials

Frequently asked questions

Intraocular Lens (IOL) Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Intraocular Lens (IOL) Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Intraocular Lens (IOL) Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live Intraocular Lens (IOL) Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.